Daily as of 2 Nov 16:00 ET
- Price
- above both $110.16 vs 50 $104.21 / 200 $101.63
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 16 Sep 2026 · projected 30 bars out · tested 1 bar
ABT | Abbott LaboratoriesNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history
$110.16
+$3.96 (+3.73%)
Abbott Laboratories (ABT) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.
The 50 SMA has sat above the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $106.20 vs 50 $105.65 / 200 $112.47
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross week of 27 Jul 2026 · projected 27 bars out · tested 5 bars
4-hour as of 3 Nov 16:00 ET
- Price
- above both $109.40 vs 50 $102.32 / 200 $102.31
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 26 Oct 2026 bar 2 · projected 12 bars out · tested 2 bars
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 26 Oct 2026 | 💀Death | 4-hour | 12 bars out | 2 bar cross test |
| 16 Sep 2026 | 🟨Golden steep | daily | 30 bars out | 1 bar cross test |
| 28 Jul 2026 | 🟨Golden | 4-hour | 20 bars out | Not tested |
| week of 27 Jul 2026 | 💀Death steep | weekly | 27 bars out | 5 bar cross test |
| 5 Nov 2025 | 💀Death moderate | daily | 24 bars out | 1 bar cross test |
About ABT
ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$831M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandlarge